T-Cell Lymphoma: From Diagnosis to Treatment
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 31 May 2026 | Viewed by 1
Special Issue Editors
Interests: cutaneous lymphoma (CTCL); Hodgkin lymphoma; leukemia; non-Hodgkin lymphoma
Special Issue Information
Dear Colleagues,
Cutaneous and peripheral T-cell lymphomas (CTCL and PTCL) represent a heterogeneous group of malignancies characterized by variable clinical presentations, diverse molecular landscapes, and often unpredictable responses to therapy. Among these, Sezary syndrome (SS) and mycosis fungoides (MF) exemplify the complex interplay between cellular origin, genetic aberrations, and microenvironmental influences that underpin disease heterogeneity and therapeutic resistance. Despite advances in diagnosis and treatment, achieving durable remission remains a significant clinical challenge, highlighting the urgent need to deepen our understanding of the molecular and immunologic mechanisms driving these diseases.
This Special Issue seeks to elucidate critical, interconnected facets of T-cell lymphomagenesis and therapeutic vulnerability, spanning cellular, genetic, epigenetic, and immunologic dimensions. Together, this series presents a cohesive narrative from cellular origin to cutting-edge therapy, uniting mechanistic insights with clinical relevance. The novel findings highlighted herein ranging from the impact of clonotypic heterogeneity and driver mutations to the therapeutic promise of epigenetic modulation and immunotherapy offer a roadmap for precision medicine in T-cell lymphomas. By integrating these discoveries into clinical practice, hematologists, oncologists, and pathologists are better equipped to predict disease behavior, tailor interventions, and ultimately improve patient outcomes in a landscape that has long been defined by complexity and unmet need.
Dr. Lubomir Sokol
Dr. Yumeng Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cutaneous T-cell lymphomas (CTCLs)
- peripheral T-cell lymphomas (PTCLs)
- Sezary syndrome (SS)
- mycosis fungoides (MF)
- genetic
- epigenetic
- therapeutic strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
